28
Sat, Mar
59 New Articles

Schoenherr and Hochedlinger Luschin Marenzi Kapsch Advise on Neuraxpharm's Acquisition of Easypharm

Schoenherr and Hochedlinger Luschin Marenzi Kapsch Advise on Neuraxpharm's Acquisition of Easypharm

Austria
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Schoenherr has advised Neuraxpharm, a portfolio company of Apax Partners, on the acquisition of Austrian consumer healthcare company Easypharm OTC GmbH. Hochedlinger Luschin Marenzi Kapsch advised the unidentified sellers on the deal, which closed on January 20, 2020.

According to Schoenherr, “Neuraxpharm Group is a European specialty pharmaceutical company focused on central nervous system disorders. With the acquisition of Easypharm, the company further consolidates its expansion into the Austrian market. Easypharm is a pharmaceutical company that focuses on consumer healthcare mainly via its two CNS brands, easysleep and easyrelax.”

Schoenherr’s team was led by Partner Sascha Hoedl, Counsel Maximilian Lang, Attorney Teresa Waidmann, and Associate Leon Scheicher.

Hochedlinger Luschin Marenzi Kapsch's team included Senior Partners Gerhard Hochedlinger and Wolfgang Luschin.

Our Latest Issue